In vivo USPIO magnetic resonance imaging shows that minocycline mitigates macrophage recruitment to a peripheral nerve injury
- Pejman Ghanouni†1,
- Deepak Behera†1,
- Jin Xie2,
- Xiaoyuan Chen3,
- Michael Moseley1 and
- Sandip Biswal1Email author
© Ghanouni et al;licensee BioMed Central Ltd. 2012
Received: 10 February 2012
Accepted: 18 June 2012
Published: 28 June 2012
Minocycline has proven anti-nociceptive effects, but the mechanism by which minocycline delays the development of allodynia and hyperalgesia after peripheral nerve injury remains unclear. Inflammatory cells, in particular macrophages, are critical components of the response to nerve injury. Using ultrasmall superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI) to monitor macrophage trafficking, the purpose of this project is to determine whether minocycline modulates macrophage trafficking to the site of nerve injury in vivo and, in turn, results in altered pain thresholds.
Animal experiments were approved by Stanford IACUC. A model of neuropathic pain was created using the Spared Nerve Injury (SNI) model that involves ligation of the left sciatic nerve in the left thigh of adult Sprague–Dawley rats. Animals with SNI and uninjured animals were then injected with/without USPIOs (300 μmol/kg IV) and with/without minocycline (50 mg/kg IP). Bilateral sciatic nerves were scanned with a volume coil in a 7 T magnet 7 days after USPIO administration. Fluid-sensitive MR images were obtained, and ROIs were placed on bilateral sciatic nerves to quantify signal intensity. Pain behavior modulation by minocycline was measured using the Von Frey filament test. Sciatic nerves were ultimately harvested at day 7, fixed in 10% buffered formalin and stained for the presence of iron oxide-laden macrophages. Behavioral measurements confirmed the presence of allodynia in the neuropathic pain model while the uninjured and minocycline-treated injured group had significantly higher paw withdrawal thresholds (p < 0.011). Decreased MR signal is observed in the SNI group that received USPIOs (3.3+/−0.5%) compared to the minocycline-treated SNI group that received USPIOs (15.2+/−4.5%) and minocycline-treated group that did not receive USPIOs (41.2+/−2.3%) (p < 0.04). Histology of harvested sciatic nerve specimens confirmed the presence USPIOs at the nerve injury site in the SNI group without minocycline treatment.
Animals with neuropathic pain in the left hindpaw show increased trafficking of USPIO-laden macrophages to the site of sciatic nerve injury. Minocycline to retards the migration of macrophages to the nerve injury site, which may partly explain its anti-nociceptive effects. USPIO-MRI is an effective in vivo imaging tool to study the role of macrophages in the development of neuropathic pain.
KeywordsNeuropathic pain Macrophages Magnetic resonance imaging Iron-oxide nanoparticles Spared-nerve injury model
Macrophages and other monocyte derivatives, as much as pain-sensing neurons themselves, play a critical role in the generation of chronic pain conditions. Macrophages are derived from the myelo-monocytic stem cells in the bone marrow and play an important role in immunity, inflammation and tissue remodeling. In the setting of nerve injury, macrophages and microglia migrate to various tissues and, as part of the healing response to injury, elaborate a variety of inflammatory factors . In an animal model of peripheral nerve injury, for example, investigators have found that monocytes migrate into the spinal cord, dorsal root ganglia and involved spinal nerve roots, and differentiate into macrophages or microglia . Because of their pro-inflammatory properties, recruitment and activation of monocyte derivatives to the nervous system is thought to promote hypersensitivity and chronic pain states.
An in vivo magnetic resonance imaging (MRI)-based method using magnetic nanoparticles, such as superparamagnetic iron-oxide particles (SPIOs), ultrasmall SPIOs (USPIOs), monocrystalline iron-oxide particles (MIONs) and cross-linked iron oxide (CLIO) has been developed to track macrophage and T-cell migration and localization . Ultrasmall superparamagnetic iron-oxide magnetic resonance imaging (USPIO-MRI) allows monitoring of trafficking of macrophages into the central nervous system in a variety of degenerative neurological conditions . SPIOs have also been used to monitor monocytic/macrophage migration patterns in the setting of rheumatoid arthritis. After intravenous injection of SPIO particles, cells that reside in the reticuloendothelial system (RES), including macrophages, engulf the agent. Because macrophages are recruited to inflamed joints, monitoring their distribution by SPIO-based techniques can be helpful, especially during early phases of the disease. MRI can be used to study the migration of these cells from the RES to inflamed joints. Investigators have successfully documented the migration of SPIO-labeled macrophages to the synovium of a rat model of RA .
Another method to monitor T-cell traffic has been developed for MRI. T-cells isolated from a subject can be loaded with dextran-coated SPIO or similar dextran-coated CLIO [6, 7]. When exposed to SPIO, T-cells will engulf the 30 nm particles by endocytosis. The T-cells are eventually re-introduced into the subject, and the subject is scanned. On gradient-echo sequences, cells carrying this contrast agent appear low in signal intensity owing to the large susceptibility effect generated by the sequestered SPIO particles. In rat models of cardiac, renal and lung allograft rejection, migration of SPIO-labeled T-cells to the allograft has been found during rejection [8–10].
Using USPIO-MRI as a surrogate marker for macrophage recruitment, we sought 1) to detect nociception-related spatiotemporal USPIO-MRI signal changes in a peripheral nerve after injury in vivo- in a longitudinal animal model of pain, 2) to determine whether chronic pain states correlate with macrophage recruitment, and 3) to determine whether USPIO-MR can be used to monitor the known effect of the antibiotic minocycline on macrophage trafficking to the site of nerve injury and whether this in turn results in altered pain thresholds.
Minocycline affects pain behaviors
Minocycline alters trafficking of USPIO-laden macrophages
Histologic presence of iron-laden macrophages at the site of nerve injury is dependent upon minocycline treatment
After nerve injury, Schwann cells generate inflammatory chemoattractants that recruit macrophages to the site of nerve injury, where these cells initiate an inflammatory cascade involving release of cytokines such as monocyte chemoattractant protein-1 (MCP-1), interleukins, and nerve growth factor as part of the process of Wallerian degeneration . However, both centrally and peripherally, this inflammatory process can result in the development of neuropathic pain .
For example, mutations in mice that result in delayed or absent macrophage activation, such as knockouts of the chemokine receptor chemotactic cytokine receptor 2 (CCR2), have impaired neuropathic pain responses . Alternatively, MCP-1 upregulation in the spinal cord is associated with increased pain hypersensitivity . B7-H1 (−/−) mice, which possess enhanced macrocytic and T cell responses to injured peripheral nerves, exhibit more pronounced mechanical hyperalgesia . Minocycline prevents the development of allodynia, and retards the migration of macrophages to the nerve injury site. The mechanism of minocycline action may be due to inhibition of matrix metalloproteases and inhibition of angiogenic factors, thereby preventing breakdown of the blood-nervous system barrier and revascularization .
In our study, animals with neuropathic pain in the left hindpaw show increased migration of USPIO-laden macrophages to the site of sciatic nerve injury, suggesting that USPIO-MRI is an effective tool to study the role of macrophages in the development of neuropathic pain. If we could take a picture of an individual’s pain-sensing circuits and highlight which foci are associated with abnormal macrophage infiltration/microglia activation, this would be invaluable in helping to objectively diagnose an individual’s cause of chronic pain. Our ability to correlate minocycline’s effect on the development of neuropathic pain with the effect of minocycline in vivo on macrophage recruitment suggests a role for this imaging tool in pre-clinical development of new drugs for pain control or in facilitating clinical image-guided therapies. Although currently not commercially available, iron oxide-based MRI has already been developed and approved for human use; Feridex©and Combidex© (feroxumide injectable solutions, AMAG Pharmaceuticals, Inc., Cambridge, MA) have been available for clinical use, for example. Identifying patients with macrophage infiltration or microglial activation along nociceptive pathways in the nervous system will help localize and characterize chronic pain pathways and could promote the use of analgesic regimens that include macrophage inhibitors such as minocycline.
Animals with neuropathic pain in the left hindpaw show increased trafficking of USPIO-laden macrophages to the site of sciatic nerve injury. Minocycline appears to retard the migration of macrophages to the nerve injury site, which may partly explain its anti-nociceptive effects. USPIO-MRI is an effective tool to study the role of macrophages in vivo in the development of neuropathic pain and, thus, may aid in the development of novel analgesics and has the potential to be used to study macrophage behavior and localization in living human subjects who suffer from chronic pain.
Experiments were carried out using adult Sprague–Dawley rats weighing 200-250 g. The Peripheral Nerve Injury Model (Neuropathic Model), otherwise known as the ‘spared nerve injury’ (SNI) model, served as a model of persistent peripheral neuropathic pain . Briefly, under isoflurane anesthesia, the rat left sciatic nerve was exposed above the trifurcation, and then the tibial and common peroneal nerves were isolated, ligated, and cut, leaving the sural nerve intact. These animals develop hyperalgesia and allodynia within ~3 days after injury.
Ultrasmall paramagnetic iron oxide (USPIO) particle preparation
Oleate coated iron oxide nanoparticles (15 nm) were obtained from Ocean NanoTech (Springdale, AR). For surface modification, about 50 mg of oleate coated nanoparticles were dispersed in 10 ml of chloroform. Forty milligrams of dopamine in 10 ml DMSO were added to the solution. The mixture was heated at 70 °C for 1 hour, and then cooled down to room temperature. Hexane was used to precipitate the nanoparticles, which were then centrifuged at 15,000xg for 15 minutes, dried with nitrogen, and redispersed in DMSO via sonication. The nanoparticles were added to a solution of 50 mg HSA in borate buffer (50 nM, pH 8.5), and dialyzed against PBS buffer (pH 7.4) for 24 h. The nanoparticles were centrifuged at 30,000 g for 20 minutes to remove the free HSA, and were redispersed in PBS buffer. Small aggregates were removed by passing the particles through a syringe filter (0.22 μm).
USPIO-magnetic resonance imaging (MRI) and minocycline treatment
All MRI experiments were performed on a small animal imaging unit (7.0 T Magnex; GE Medical Systems) located in the Small Animal Center for In-Vivo Imaging in the Clark Center at Stanford University School of Medicine. Animals were anesthetized with humidified, oxygen-enriched 2-4% isoflurane administered via nose cone. Animals were placed in a rodent holder and then into a rat quadrature body coil. Temperature and respiration were monitored during the imaging procedure. While under anesthesia and immediately after nerve injury, animals received an intravenous USPIO injection (300 μmol/kg IV; mean particle size of 20 nm) with or without minocycline (50 mg/kg IP QD, Sigma-Aldrich, St. Louis, MO). Additional doses of USPIO were administered 24 hours prior to MR imaging. Animals were imaged at post-operative day 7. A FIESTA (Fast Imaging Employing Steady State Acquisition) sequence, with TE/TR/FA of 11/22/20, slice thickness of 1 mm and in plane resolution of 0.11 x 0.11 mm was used. Using Osirix image analysis software, regions of interest were circled on bilateral sciatic nerves to quantify signal intensity, which was then normalized to background signal in the muscle.
Pain behavior measurements
A logarithmic series of calibrated monofilaments (Von Frey hairs; Stoelting, Wood Dale, IL) were applied to the left and right hindpaws to determine the threshold stiffness required for 50% paw withdrawal. Log stiffness of the hairs is defined as log10(milligrams x 10) and ranged from 3.61 (407 mg) to 5.18 (15,136 mg). The log stiffness that would have resulted in a 50% paw withdrawal rate was computed by fitting a Gaussian integral psychometric function to the observed withdrawal rates for each of the tested von Frey hairs using a maximum likelihood fitting method that allows parametric statistical analysis.
Extracted intact sciatic nerves proximal to the site of ligature were harvested after the animal was euthanized on day 7 after imaging. Samples were fixed and stained either with hematoxylin and eosin, or with Perl’s stain for iron per standard protocols.
Data were analyzed by one-way ANOVA performed on GraphPad Prism (San Diego, CA), with p value <0.05 accepted as significant.
Magnetic resonance imaging
Ultrasmall paramagnetic iron-oxide
Fast imaging employing steady state acquisition.
We like to thank Drs. Laura Pisani and Timothy Doyle for their assistance with the small animal magnetic resonance imaging device and Small Animal Imaging Facility at Stanford University. We also like to acknowledge Dr. Donald Regula for his help in interpretation of the histology, Drs. Erin Milligan and Jenny Wilkerson (her graduate student at that time) for their assistance with the von Frey test, and Soren Rasmussen for help in the figure presentation.
- Scholz J, Woolf CJ: The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007, 10: 1361–1368. 10.1038/nn1992View ArticlePubMed
- Watkins LR, Maier SF: Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 2002, 82: 981–1011.View ArticlePubMed
- Thorek DLJ, Czupryna J, Chen AK, Tsourkas A: Molecular Imaging of Cancer with Superparamagnetic Iron Oxide Particles. In Cancer Imaging: Instrumentation and Applications. Edited by: Hayat MA. Elsevier Acad Press, San Diego; 2008:85–95.View Article
- Stoll G, Bendszus M: Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging. Neuroscience 2009, 158: 1151–1160. 10.1016/j.neuroscience.2008.06.045View ArticlePubMed
- Beckmann N, Falk R, Zurbrugg S, Dawson J, Engelhardt P: Macrophage infiltration into the rat knee detected by MRI in a model of antigen-induced arthritis. Magn Reson Med 2003, 49: 1047–1055. 10.1002/mrm.10480View ArticlePubMed
- Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP, Ho C: Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J 1999, 76: 103–109. 10.1016/S0006-3495(99)77182-1PubMed CentralView ArticlePubMed
- Josephson L, Kircher MF, Mahmood U, Tang Y, Weissleder R: Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem 2002, 13: 554–560. 10.1021/bc015555dView ArticlePubMed
- Kanno S, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C: A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection. J Thorac Cardiovasc Surg 2000, 120: 923–934. 10.1067/mtc.2000.110184View ArticlePubMed
- Kanno S, Wu YJ, Lee PC, Dodd SJ, Williams M, Griffith BP, et al.: Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 2001, 104: 934–938. 10.1161/hc3401.093148View ArticlePubMed
- Zhang Y, Dodd SJ, Hendrich KS, Williams M, Ho C: Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltration. Kidney Int 2000, 58: 1300–1310. 10.1046/j.1523-1755.2000.00286.xView ArticlePubMed
- Martini R, Fischer S, Lopez-Vales R, David S: Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia 2008, 56: 1566–1577. 10.1002/glia.20766View ArticlePubMed
- Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, et al.: Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA 2003, 100: 7947–7952. 10.1073/pnas.1331358100PubMed CentralView ArticlePubMed
- Gao YJ, Zhang L, Samad OA, Suter MR, Yasuhiko K, Xu ZZ, et al.: JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 2009, 29: 4096–4108. 10.1523/JNEUROSCI.3623-08.2009PubMed CentralView ArticlePubMed
- Uceyler N, Gobel K, Meuth SG, Ortler S, Stoll G, Sommer C, et al.: Deficiency of the negative immune regulator B7-H1 enhances inflammation and neuropathic pain after chronic constriction injury of mouse sciatic nerve. Exp Neurol 2010, 222: 153–160. 10.1016/j.expneurol.2009.12.026View ArticlePubMed
- Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF, et al.: Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005, 115: 71–83. 10.1016/j.pain.2005.02.009View ArticlePubMed
- Decosterd I, Woolf CJ: Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000, 87: 149–158. 10.1016/S0304-3959(00)00276-1View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.